Member Info for Dr_Horrible

"We expect to announce at least one new collaboration by November and confirm the Board's intention to explore a possible fundraise over the coming weeks to scale our commercial strategy'

At least one new collaboration by November. So there will likely be some good news in the next 5 weeks.

The product page on their website.

https://www.icharming.co/products/icharming-crystal-eye-nutrition-1-1-1?fbclid=IwVERFWAM7lyNleHRuA2FlbQIxMQABHhIaHry9DqaNi5ZTv4wrVtaLJZnPQAMcCwLQp637BYKzIw0FQYFu0elazbXX_aem_YFdvFSehPMMK100wjQ3AnA

There seems to be a new product from I-Charming. We have previously seen Eye Nutrition, but this one is for hair.

https://www.facebook.com/share/p/1CL1TnudR3/?mibextid=wwXIfr

I told Gemini everything we know and it said it’s best guess was between October and April.

My expectations are uninspiring results, probably around £1.3m. I just hope it’s not less than that.

2 years ago today. :(

I think that stamp of approval will have a ripple effect. For the big players FF will stand out from the crowd.

Maybe they ordered stock, but just to cover the existing customers and they will need to do another bigger order when DSM or BH make significant order, and for that they will need funding. I doubt they would raise money via an open offer as that takes time. Would be nice if they would tell us.

Looks like AFC SOP Subarashi Gold is now ready to replace the old AFC SOP Subarashi.

https://www.instagram.com/p/DMxv1i9PmTL/

Not sure if there is more FF in it or not.

"Subject to the outcome of ongoing negotiations with a third party, the Company might also be able to hold some of its future stock requirements on a consignment basis, only paying for the stock when it was required for sale."

'Some' of its stock. And I assume this would only be a workaround for a limited period of time whilst there are funding challenges.

I've never been overly concerned about the Tomato Foundation research, they were barking up the wrong tree. They were trying to obtain EFSA approval for all or any tomatoes. There are many varieties, sizes, growing conditions and varying polyphenol levels. Therefore, the product is not consistent at all and there is no quality control. Probably no responsible party either. The quantities required to obtain a given effect could differ wildly. It goes totally against the EFSA evaluation methods. They want consistency and quality control, you take this amount of x and this is the effect, proven, consistent and batch tested.

12p and don’t call him Shirley :)

When SAMR approval comes, the share price should fly. However, it depends of a few things. What size is the initial order and do they make clear that it pushed the company into profit? Do they tell us how frequent the orders will likely be? Do they require additional funding? Do they tell us any information about BH plans for their own products? Do they tell us how many business customers or prospective business customers BH have?

It should be the start of a period of rapid growth.

Perhaps DSM gut health products land before China. Time will tell.

Just think how attractive FF will be to major companies in China. At the moment to gain Blue Hat approval, companies have to submit their end-product, along with clinical trial details (or alternative supporting evidence) etc to prove the efficacy and safety of the product. If they require clinical trials, it can cost them a significant amount of money and take ages, then the submission itself costs quite a bit and there is no guarantee that it will be approved. Now Fruitflow will be in a totally unique position where the FF ingredient is essentially pre-approved for the Platelet Aggregation claim and nobody else can make that claim for 5 years, so any companies that are using a standard dose (150mg) of FF-II SD will not need to do a clinical trial for the platelet aggregation claim. When they submit for Blue Hat, it will just be the more routine aspects that will need approval, safety, stability, manufacturing quality, labelling compliance etc. This massively speeds things up, reduces cost and reduces risk. FF will be the only pre-approved health claim ingredient in China.

Then there is a chance that SAMR may speed up Blue Hat approvals, as BH are rolling this out to specifically target a risk highlighted in the HC2030 policy. Not sure that will happen though, as they don't seem to be speeding up the FF approval. It is the kinda thing they do.

To-date we know of no other ingredient that has been submitted under the New Health Claims approval process, so it looks like this unique position will held for some time.

So when it was reported in industry news that BH have agreements from a large number of multi-national supplement and food/beverage companies to commercialise FF in China, it's easy to see why they would all be so interested. They can fairly easy get a scientifically backed, Blue Hat approved product into shops and chemists in a relatively short period of time without huge cost outlay and risk, that also aligns with HC2030.

China has amongst the most restrictive health claims regulations. If Globals, the likes of Nestle (Nature's Bounty) launch new FF products in China, it is easy to see how they would then roll that product out to other countries if it were successful, which it likely would be given it's uniqueness and lack of competition.

Come on SAMR.

The product has been launched in Singapore, Malaysia and Brunei so far. They will no doubt have a period of monitoring and feedback before launching to further countries. Amway is a large company with approve $7.5bn revenue. It’s the world’s biggest direct-selling supplement company. Let’s hope it goes well :)

May be 7mins ish.

Https://amwayappssg.amway2u.com/amway/publish/programmes/2025/05%20HWJ%20-%20Power%20in.%20Rebound%20strong.%20Meet%20your%202%20new%20essentials%21%20Introducing%20XS%20Booster%20%26%20Whey%20Protein%20Powder%20Janjira.mp4

Skip to 10mins 40s.

It’s only on the Disocver Biotics infographic.

The most trades we've seen in a long time.

Whilst we have no idea what the revenue from FF will be for H2, we do know that ON Pump has been fully rolled out since then. Even thought its only 50mg per dose, its probably a good order size. Also, there is a chance that it also includes an order from Amway, perhaps in Feb/March, so that they could ready their product for the June launch. It's now launched in Malaysia and pre-launch in Singapore. Looks likely to be rolling out to many other countries.